pep1

General Information


DRACP ID  DRACP01760

Peptide Name   pep1

Sequence  EARPALLTSRLRFIPK

Sequence Length  16

UniProt ID  O14746 

PubChem CID  Not available

Origin  Not available

Type  Synthetic peptide

Classification

  

Active ACP



Activity Information


Cell Line Disease Cancer Classified Activity Assay Testing Time Literature
AsPC-1 Pancreatic ductal adenocarcinoma Carcinoma Significantly inhibiting fibrosis of AsPC1 Cell Xenograft experiments Not available Patent

Hemolytic Activity  Not available

Normal (non-cancerous) Cytotoxicity  Not available

Target  Not available

Affinity  Not available

Mechanism  Not available

Nature  Anticancer; Antitumor



Structure Information


PDB ID  Not available

Predicted Structure  DRACP01760

Helicity  Not available

Linear/Cyclic  Linear

Disulfide/Other Bond  Not available

N-terminal Modification  Free

C-terminal Modification  Free

Other Modification  None

Chiral  L



Physicochemical Information


Formula  C85H146N26O21

Absent amino acids  CDGHMNQVWY

Common amino acids  LR

Mass  213598

Pl  12.22

Basic residues  4

Acidic residues  1

Hydrophobic residues  7

Net charge  3

Boman Index  -3681

Hydrophobicity  -20.63

Aliphatic Index  110

Half Life 
  Mammalian: 2.8 hour
  Yeast: 10 min
  E.coli: 2 min

Extinction Coefficient cystines  0

Absorbance 280nm  0

Polar residues  2

Amino acid distribution



Literature Information


Literature 1

Pubmed ID Not available

Title  Not available

Doi Not available

Year  Not available

Patent

Patent ID US2017/0028035A1

Patent Title  Peptide Having Fibrosis Inhibitory Activity and Composition Containing Same

Other Iinformation  Patent Application; Family: 14s / 14ex; Family Jurisdictions: CN, EP, US, JP, KR, WO; Legal Status: Active; Application No: 201515303370; Filed: Apr 10, 2015; Published: Feb 2, 2017; Earliest Priority: Apr 11, 2014; Granted: Apr 10, 2018

Other Published ID  CN106456697A  CN106456697B  EP3130345A1  EP3130345A4  EP3130345B1  JP2017513941A  JP2018193384A  JP6420459B2  JP6748155B2  KR20160135358A  US2018207241A1  US9937240B2  WO2015156649A1 




DRACP is developed by Dr.Zheng's team.